Clinical trial
Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic…
NCT00186342 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186342 |
|---|---|
| Title | Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies |
| Official title | Allogeneic Sibling and Unrelated Donor Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Busulfan, Etoposide and Cyclophosphamide |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Acute Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic, Myeloproliferative Disorders, Blood and Marrow Transplant (BMT), Myelodysplastic Syndromes (MDS) |
| Intervention type | Procedure |
| Interventions | ablative allogeneic hematopoietic cell transplantation |
| Enrollment | 120 |
| Start date | Sep 1, 1992 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 17, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: